Search Results - Danielle Armas
- Showing 1 - 4 results of 4
-
1
Bioequivalence and food effect of a fixed‐dose combination of macitentan and tadalafil: Adaptive design in the COVID‐19 pandemic by Dénes Csonka, Vladislav Fishman, Jaya Natarajan, Hans Stieltjes, Danielle Armas, Victor Dishy, Juan Jose Perez Ruixo
Published in Pharmacology Research & Perspectives (2021-10-01)Get full text
Article -
2
Assessment of QT Interval Prolongation Using Concentration–QT Modeling for Iptacopan, an Oral Complement Factor B Inhibitor, in Healthy Individuals by Noemi Kaetterer, Kenneth Kulmatycki, Prasanna Kumar Nidamarthy, Elizabeth McNamara, Danielle Armas, Venkateswar Jarugula, Robert Schmouder
Published in Clinical and Translational Science (2025-10-01)Get full text
Article -
3
A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants by Shichang Miao, Peter Staehr, Ezra Tai, Borje Darpo, Hongqi Xue, Danielle Armas, Kenneth Webster, Rajneet K. Oberoi
Published in Clinical and Translational Science (2024-07-01)Get full text
Article -
4
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19 by Flonza Isa, Eduardo Forleo-Neto, Jonathan Meyer, Wenjun Zheng, Scott Rasmussen, Danielle Armas, Masaru Oshita, Cynthia Brinson, Steven Folkerth, Lori Faria, Ingeborg Heirman, Neena Sarkar, Bret J. Musser, Shikha Bansal, Meagan P. O'Brien, Kenneth C. Turner, Samit Ganguly, Adnan Mahmood, Ajla Dupljak, Andrea T. Hooper, Jennifer D. Hamilton, Yunji Kim, Bari Kowal, Yuhwen Soo, Gregory P. Geba, Leah Lipsich, Ned Braunstein, George D. Yancopoulos, David M. Weinreich, Gary A. Herman
Published in International Journal of Infectious Diseases (2022-09-01)Get full text
Article